Feng Xue

2.2k total citations
146 papers, 1.3k citations indexed

About

Feng Xue is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Feng Xue has authored 146 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hematology, 35 papers in Molecular Biology and 34 papers in Genetics. Recurrent topics in Feng Xue's work include Platelet Disorders and Treatments (69 papers), Hemophilia Treatment and Research (36 papers) and Blood groups and transfusion (29 papers). Feng Xue is often cited by papers focused on Platelet Disorders and Treatments (69 papers), Hemophilia Treatment and Research (36 papers) and Blood groups and transfusion (29 papers). Feng Xue collaborates with scholars based in China, United States and Canada. Feng Xue's co-authors include Renchi Yang, Lei Zhang, Huiyuan Li, Rongfeng Fu, Donglei Zhang, Haifeng Zhao, Jing Ge, Xiao Fan Liu, Zeping Zhou and Weiting Du and has published in prestigious journals such as Nature Medicine, Blood and PLoS ONE.

In The Last Decade

Feng Xue

131 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Xue China 20 651 350 238 191 131 146 1.3k
Yiming Wang Canada 16 436 0.7× 225 0.6× 95 0.4× 153 0.8× 44 0.3× 38 1.2k
Elba Reyes‐Maldonado Mexico 17 346 0.5× 232 0.7× 115 0.5× 278 1.5× 43 0.3× 75 976
Pingguo Chen Canada 17 855 1.3× 146 0.4× 98 0.4× 233 1.2× 142 1.1× 29 1.3k
Camille Ettelaie United Kingdom 21 464 0.7× 488 1.4× 89 0.4× 228 1.2× 32 0.2× 68 1.4k
Rossana Porcasi Italy 19 173 0.3× 319 0.9× 126 0.5× 296 1.5× 258 2.0× 41 1.4k
Frances M. Gibson United Kingdom 20 755 1.2× 335 1.0× 314 1.3× 383 2.0× 45 0.3× 56 1.4k
Jin Lu China 18 546 0.8× 547 1.6× 158 0.7× 198 1.0× 89 0.7× 138 1.2k
Francesco La Rocca Italy 20 218 0.3× 592 1.7× 170 0.7× 166 0.9× 102 0.8× 62 1.3k
Julie Rayes United Kingdom 21 696 1.1× 405 1.2× 172 0.7× 562 2.9× 29 0.2× 45 1.7k

Countries citing papers authored by Feng Xue

Since Specialization
Citations

This map shows the geographic impact of Feng Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Xue more than expected).

Fields of papers citing papers by Feng Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Xue. The network helps show where Feng Xue may publish in the future.

Co-authorship network of co-authors of Feng Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Xue. A scholar is included among the top collaborators of Feng Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Xue. Feng Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Feng, Tienan Zhu, Zeping Zhou, et al.. (2025). Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials. Nature Medicine. 32(1). 93–102.
2.
Sun, Ting, Jia Chen, Xiaofan Liu, et al.. (2024). Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study. British Journal of Haematology. 205(5). 1938–1950. 1 indexed citations
3.
Yu, Dandan, Feng Xue, Yunfei Chen, et al.. (2024). Acquired hemophilia A: a single-center study of 165 patients. Research and Practice in Thrombosis and Haemostasis. 8(1). 102318–102318. 2 indexed citations
4.
Sun, Ting, Jia Chen, Yuan Xu, et al.. (2024). Proteomics landscape and machine learning prediction of long‐term response to splenectomy in primary immune thrombocytopenia. British Journal of Haematology. 204(6). 2418–2428. 3 indexed citations
6.
Xue, Feng & Lai Wei. (2024). THR-β Agonist for Nonalcoholic Steatohepatitis Treatment: Challenges of a Promising Drug. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
7.
Zhou, Yu‐Feng, et al.. (2024). Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 44(7). 539–548. 1 indexed citations
8.
Jing, Weiqing, Christina K. Baumgartner, Feng Xue, Jocelyn A. Schroeder, & Qizhen Shi. (2023). Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cells. Journal of Thrombosis and Haemostasis. 21(3). 488–498. 3 indexed citations
9.
Dong, H., Anqi Zhang, Xiaofan Liu, et al.. (2023). Increased reactive oxygen species lead to overactivation of platelets in essential thrombocythemia. Thrombosis Research. 226. 18–29. 4 indexed citations
11.
Fu, Rongfeng, H. Dong, Donglei Zhang, et al.. (2023). Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China. Annals of Hematology. 102(8). 2097–2107. 1 indexed citations
12.
Zhang, Wenhui, Man‐Chiu Poon, Runhui Wu, et al.. (2022). Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China. Haemophilia. 29(1). 123–134. 6 indexed citations
13.
Xue, Feng, et al.. (2022). Circ_0035381 Regulates Acute Myeloid Leukemia Development by Modulating YWHAZ Expression via Adsorbing miR-582-3p. Biochemical Genetics. 61(1). 354–371. 8 indexed citations
14.
15.
Li, Yanfei, Boyang Sun, Yu Huang, et al.. (2017). [Predictors of fatigue among individuals with primary immune thrombocytopenia in China].. PubMed. 38(5). 384–389. 1 indexed citations
16.
Lyu, Cuicui, Jun Shen, Jianping Zhang, et al.. (2017). The State of Skewed X Chromosome Inactivation is Retained in the Induced Pluripotent Stem Cells from a Female with Hemophilia B. Stem Cells and Development. 26(13). 1003–1011. 3 indexed citations
17.
Guan, Yue, Shixuan Wang, Feng Xue, et al.. (2016). Long‐term results of splenectomy in adult chronic immune thrombocytopenia. European Journal Of Haematology. 98(3). 235–241. 30 indexed citations
18.
Lyu, Cuicui, Feng Xue, Wei Liu, et al.. (2016). Identification of mutations in theF8andF9gene in families with haemophilia using targeted high‐throughput sequencing. Haemophilia. 22(5). e427–34. 6 indexed citations
19.
Fu, Rongfeng, Min Xuan, Liyan Zhang, et al.. (2014). External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET‐thrombosis) in a large cohort of Chinese patients. European Journal Of Haematology. 92(6). 502–509. 19 indexed citations
20.
Xue, Feng. (2005). Induction of Human Umbilical Cord Blood Mesenchymal Stem Cells into Nerve - Like Cells by Salvia Miltior-rhiza. Testowy IndexCopernicus. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026